Premier (PINC) to Release Quarterly Earnings on Tuesday

Premier (NASDAQ:PINC) is expected to be releasing its earnings data before the market opens on Tuesday, February 4th. Analysts expect Premier to post earnings of $0.29 per share and revenue of $243.51 million for the quarter. Premier has set its FY 2025 guidance at 1.160-1.280 EPS and its FY25 guidance at $1.16 to $1.28 EPS.Persons interested in listening to the company’s earnings conference call can do so using this link.

Premier (NASDAQ:PINC) last released its earnings results on Tuesday, November 5th. The company reported $0.34 EPS for the quarter, topping the consensus estimate of $0.25 by $0.09. Premier had a net margin of 11.41% and a return on equity of 10.74%. The company had revenue of $248.14 million during the quarter, compared to analysts’ expectations of $232.85 million. During the same quarter last year, the business earned $0.50 EPS. The business’s revenue was down 7.8% on a year-over-year basis. On average, analysts expect Premier to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Premier Stock Down 1.5 %

Shares of Premier stock opened at $22.66 on Monday. The firm has a market cap of $2.18 billion, a price-to-earnings ratio of 16.66 and a beta of 0.43. The company’s 50-day simple moving average is $21.92 and its 200-day simple moving average is $20.94. Premier has a 52-week low of $17.95 and a 52-week high of $23.56.

Premier Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Saturday, March 15th. Stockholders of record on Saturday, March 1st will be issued a $0.21 dividend. The ex-dividend date is Friday, February 28th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 3.71%. Premier’s dividend payout ratio is presently 61.76%.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on PINC shares. Canaccord Genuity Group raised their target price on shares of Premier from $19.00 to $21.00 and gave the company a “hold” rating in a report on Wednesday, November 6th. Robert W. Baird lifted their price objective on Premier from $19.00 to $20.00 and gave the stock a “neutral” rating in a research report on Wednesday, November 6th. Barclays increased their target price on Premier from $20.00 to $24.00 and gave the company an “equal weight” rating in a report on Wednesday, November 6th. Finally, StockNews.com cut Premier from a “buy” rating to a “hold” rating in a report on Tuesday, November 5th. Ten research analysts have rated the stock with a hold rating, Based on data from MarketBeat, Premier currently has a consensus rating of “Hold” and an average price target of $21.36.

Insider Buying and Selling at Premier

In other Premier news, Director John T. Bigalke sold 1,136 shares of the firm’s stock in a transaction that occurred on Thursday, December 5th. The stock was sold at an average price of $22.19, for a total transaction of $25,207.84. Following the completion of the sale, the director now owns 23,846 shares in the company, valued at $529,142.74. This trade represents a 4.55 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Helen M. Boudreau sold 2,500 shares of the company’s stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $21.42, for a total value of $53,550.00. Following the completion of the transaction, the director now directly owns 20,668 shares in the company, valued at approximately $442,708.56. The trade was a 10.79 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 59,425 shares of company stock valued at $1,320,242 over the last three months. 0.96% of the stock is owned by company insiders.

Premier Company Profile

Premier, Inc, together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions.